학술논문

Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status
Document Type
Article
Source
In European Urology Oncology June 2020 3(3):351-359
Subject
Language
ISSN
2588-9311